TD Asset Management Inc Has $404.28 Million Position in Thermo Fisher Scientific Inc. $TMO

TD Asset Management Inc increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 76.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 697,688 shares of the medical research company’s stock after acquiring an additional 302,676 shares during the quarter. TD Asset Management Inc’s holdings in Thermo Fisher Scientific were worth $404,275,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Greenspring Advisors LLC acquired a new stake in Thermo Fisher Scientific during the 4th quarter worth approximately $294,000. Transatlantique Private Wealth LLC boosted its position in Thermo Fisher Scientific by 0.7% during the 4th quarter. Transatlantique Private Wealth LLC now owns 5,107 shares of the medical research company’s stock worth $2,959,000 after buying an additional 33 shares during the period. BlackDiamond Wealth Management LLC acquired a new stake in Thermo Fisher Scientific during the 4th quarter worth approximately $203,000. CIBC Asset Management Inc boosted its position in Thermo Fisher Scientific by 3.5% during the 4th quarter. CIBC Asset Management Inc now owns 233,593 shares of the medical research company’s stock worth $135,341,000 after buying an additional 7,822 shares during the period. Finally, Marble Wealth LLC acquired a new stake in Thermo Fisher Scientific during the 4th quarter worth approximately $2,055,000. 89.23% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Wells Fargo & Company lowered their price target on shares of Thermo Fisher Scientific from $675.00 to $615.00 and set an “overweight” rating for the company in a report on Friday, May 8th. HSBC lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday. Weiss Ratings restated a “hold (c)” rating on shares of Thermo Fisher Scientific in a report on Wednesday, April 8th. KeyCorp restated an “overweight” rating on shares of Thermo Fisher Scientific in a report on Tuesday, May 26th. Finally, Robert W. Baird lowered their price target on shares of Thermo Fisher Scientific from $653.00 to $639.00 and set an “outperform” rating for the company in a report on Friday, April 24th. Two investment analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.67.

Thermo Fisher Scientific Stock Performance

NYSE:TMO opened at $474.25 on Thursday. The company has a fifty day moving average of $480.44 and a 200-day moving average of $532.17. The firm has a market capitalization of $176.24 billion, a P/E ratio of 26.07, a P/E/G ratio of 2.13 and a beta of 0.88. The company has a quick ratio of 1.15, a current ratio of 1.53 and a debt-to-equity ratio of 0.77. Thermo Fisher Scientific Inc. has a twelve month low of $385.46 and a twelve month high of $643.99.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Thursday, April 23rd. The medical research company reported $5.44 earnings per share for the quarter, beating the consensus estimate of $5.25 by $0.19. The company had revenue of $11.01 billion during the quarter, compared to analyst estimates of $10.86 billion. Thermo Fisher Scientific had a net margin of 15.15% and a return on equity of 16.86%. Thermo Fisher Scientific’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.15 EPS. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. As a group, sell-side analysts anticipate that Thermo Fisher Scientific Inc. will post 24.86 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Monday, June 15th will be paid a $0.47 dividend. The ex-dividend date is Monday, June 15th. This represents a $1.88 annualized dividend and a dividend yield of 0.4%. Thermo Fisher Scientific’s payout ratio is currently 10.34%.

Insider Buying and Selling at Thermo Fisher Scientific

In other news, COO Gianluca Pettiti sold 400 shares of Thermo Fisher Scientific stock in a transaction on Monday, April 27th. The shares were sold at an average price of $462.66, for a total value of $185,064.00. Following the completion of the sale, the chief operating officer owned 25,051 shares in the company, valued at $11,590,095.66. The trade was a 1.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.33% of the stock is owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.